US trade tribunal to consider new Apple Watch import ban

The U.S. International Trade Commission (ITC) has launched a new investigation to determine if redesigned Apple Watches still infringe Masimo's blood-oxygen measurement patents, following a prior import ban on certain Apple Watch models. This development coincides with a California jury's ruling that Apple must pay Masimo $634 million for patent infringement, escalating the multi-front legal dispute between the two companies. The ITC expects to conclude its investigation within six months, potentially impacting Apple's smartwatch sales featuring the contested technology.

Analysis

The U.S. International Trade Commission (ITC) has initiated a new investigation to determine if redesigned Apple Watches infringe Masimo's blood-oxygen measurement patents, following a prior import ban in 2023. This probe, targeting completion within six months, scrutinizes Apple's updated technology, which was reintroduced after initially removing the feature to circumvent the earlier ban. Apple maintains the case is meritless, asserting Masimo copied its design.

This ITC action escalates a multi-front legal battle, highlighted by a California jury's recent ruling that Apple owes Masimo $634 million for patent infringement. The dispute also involves Masimo's trade-secret theft allegations, which resulted in a 2023 mistrial, and Apple's countersuit where it secured a minimal $250 verdict. The ongoing litigation underscores significant intellectual property risks for Apple's key product lines.

The strongly negative sentiment (-0.9) for AAPL and strongly positive sentiment (0.9) for MASI reflect the perceived impact of these legal developments. The potential for further import restrictions on Apple's smartwatches, a critical product category, could affect sales and market share, despite Apple's efforts to redesign and reintroduce the contested features.

Key Decisions for Investors

• Investors should closely monitor the ITC's six-month investigation into Apple Watch patent infringement, as a renewed import ban could significantly impact Apple's wearables segment
• Evaluate the financial implications of the $634 million patent infringement judgment against Apple and the potential for further liabilities from ongoing multi-jurisdictional litigation
• Consider the broader implications of these intellectual property disputes on Apple's innovation pipeline and competitive standing in the health technology market